Events

PhRMA hosts online and in-person events exploring science and policy issues that impact biopharmaceutical innovation and patient access to medicines. With members from the nation’s leading biopharmaceutical research companies, our events offer unique insights about the future of health in America.

-

Oct 15, 2024

On October 15, PhRMA’s Chief Medical Officer, Dr. Michael Ybarra, joined Voters for Cures champion Cristi Waltz on stage at Reuters Pharma & Patient USA 2024 for the fireside chat “Transforming Patient Care and Experiences: Innovations and Advocacy in Modern Healthcare.”

learn more

-

Oct 10, 2024

On September 30, PhRMA was invited to the 2024 Fierce Biotech Summit, where Chief Public Affairs Officer and Head of Strategic Initiatives Robby Zirkelbach participated in the panel “The Strategic Powerhouse Within: The Case to Bring Communications Teams to the Table.” Robby discussed how communications teams contribute to strategic advocacy discussions, as well as the importance of managing internal and external stakeholder expectations.

learn more

-

Jul 25, 2024

On June 25, PhRMA sponsored The Atlantic’s People v. Cancer event, where Chief Operating Officer Lori Reilly led the fireside chat titled “Precision Oncology: The Future of Cancer Care.” Alongside Dan Asch, Vice President of Oncology Franchise at Boehringer Ingelheim, Lori discussed the promise of precision medicine in greatly improving cancer patient outcomes and advocated for policies that protect the oncology innovation pipeline.

learn more

-

May 31, 2024
On May 31, PhRMA held a media briefing at this year’s ASCO event, where panelists discussed the importance of federal policies that protect the future of groundbreaking oncology discoveries. Panelists included PhRMA’s President and Chief Executive Officer, Steve Ubl, Robert M. Davis, Chief Executive Officer and President, Merck & Co. Inc., Daniel O’Day, Chairman and Chief Executive Officer, Gilead Sciences, Inc. and David Ricks, Chair and Chief Executive Officer, Eli Lilly and Company.
learn more

-

May 16, 2024
On May 16, PhRMA participated in Financial Times’ US Pharma and Biotech Summit. Robby Zirkelbach, PhRMA’s Chief Public Affairs Officer and Head of Strategic Initiatives, joined a panel discussion titled, “The Impact of a Pivotal Presidential Election on the Biopharma Industry.” During the conversation, Zirkelbach discussed the future of health care policy, emphasizing key Inflation Reduction Act and pharmacy benefit manager (PBM) reforms that will better protect patient access.
learn more

-

Apr 10, 2024
On April 10, PhRMA attended Bamberg Health’s U.S. Northeast Healthcare Innovation Summit, where PhRMA’s Chief Medical Officer, Dr. Michael Ybarra, participated in the panel titled “Unlocking Access to Therapies & Medicines.” Dr. Ybarra emphasized the importance of federal policies promoting biopharmaceutical R&D and expanding access to medicines. During the session, Dr. Ybarra proposed solutions to address current federal policies that limit patient access, advocating for laws that safeguard innovation and improve patient access to medicines.
learn more

-

Mar 26, 2024
On March 26, PhRMA Executive Vice President of Policy and Research Elizabeth Carpenter joined Voters for Cures champion Terry Uhl at Reuters Pharma USA 2024 for a fireside chat highlighting the role of prevention and biopharmaceutical treatments in combatting chronic diseases. During the keynote session, “Innovation Saves Lives: Champion Policies that Improve Patient Outcomes,” Terry shared his story as a colon cancer survivor, emphasizing the biopharmaceutical industry’s role in improving patient outcomes. Elizabeth discussed laws like the Inflation Reduction Act (IRA) and the Biden Administration’s march-in rights framework that jeopardize the future of innovation. She advocated for policies that allow R&D to flourish and that expand access to new medicines and treatments.
learn more

-

Jan 9, 2024
On January 9, PhRMA Chief Operating Officer Lori Reilly sat down with Rebecca Willumson at Fierce JPM Week to discuss how to improve patient access and affordability. Advocating for increased oversight of middlemen – known as pharmacy benefit managers (PBMs) – and of the 340B program, Lori recommended policy solutions like ensuring PBMs share negotiated savings with patients at the pharmacy and making sure the 340B program reaches the low-income, vulnerable patients it was designed to help. 
learn more

-

Jan 9, 2024

On January 9, as part of PhRMA’s sponsorship of Fierce JPM Week, PhRMA President and CEO Stephen J. Ubl joined Stephanie Butler for a conversation about patient access and affordability. During the conversation, Ubl dove into harmful policies impacting biopharmaceutical innovation, such as the Biden Administration’s recently proposed march-in rights framework, and offered policy solutions that would reduce out-of-pocket costs for patients, like reforms to middlemen known as pharmacy benefit managers (PBMs).

learn more

-

Dec 7, 2023
On December 7, PhRMA participated in The Hill’s event: U.S. Healthcare’s Annual Checkup. PhRMA’s President and CEO, Stephen J. Ubl, spoke during the “Mission to End Cancer” panel about the need to develop groundbreaking innovations that provide cancer patients with affordable treatments and the policies that are standing in the way, like government price setting for medicines and attacks on IP protections. He advocated for policies that nurture advancements in oncology and reforms that address two drivers of patients’ out-of-pocket costs: PBMs and the 340B program.
learn more

-

Nov 14, 2023
On November 14, PhRMA sponsored the Washington Post’s Global Women’s Summit. PhRMA’s Executive Vice President of Policy and Research, Elizabeth Carpenter, spoke during the sponsored segment, “What’s with the Middlemen: Protecting Medicine Access and Affordability,” about the barriers that stand between patients and their care.
learn more

-

Nov 2, 2023
On November 2, 2023, PhRMA’s Dr. Michael Ybarra was invited to speak on the panel, “Innovation, Funding and Access to Orphan Drugs: Challenges and Opportunities” at the 2023 North America Rare Disease Summit. During the panel participants examined the current state of rare disease research and the policy solutions needed to advance rare disease treatment. Dr. Ybarra emphasized the harm that the Inflation Reduction Act poses to biopharmaceutical innovation, forcing the industry to rethink its crucial R&D investments, ultimately delaying groundbreaking innovations for patients living with rare diseases.
learn more

-

Oct 31, 2023
On October 31, 2023, America’s Physician Groups invited PhRMA’s Chief Medical Officer, Dr. Michael Ybarra, to speak at their 2023 Annual Fall Conference. Dr. Ybarra participated in the panel titled, “The Inflation Reduction Act: Achievements and Future Challenges,” which addressed the law’s impact on Medicare, R&D and innovation. Dr. Ybarra advocated for patient-centered solutions that will address patient access and affordability challenges without the unintended consequences of the Inflation Reduction Act’s price-setting provisions.
learn more

-

Sep 19, 2023
On September 19, 2023, Informa invited PhRMA’s Senior Vice President of State Advocacy, Scott LaGanga, to host a ”state of the industry” fireside chat with Matt Salo, Founder and CEO of Salo Health Strategies, at the Medicaid Drug Rebate Program Summit. LaGanga and Salo discussed the current state of Medicaid and the broader health care industry. They also highlighted solutions to patient access and affordability issues throughout the U.S. health care system.
learn more

-

Sep 14, 2023
On September 14, 2023, Modern Healthcare invited PhRMA’s Chief Operating Officer, Lori Reilly, to a closed-door conversation at their annual Leadership Symposium. Lori spoke on the policy-focused panel, “Campaign 2024: Healthcare on the Ballot,” where panelists shared where the policy conversation may go in years to come when it comes to health care. Lori shared the state of affordability for patients and ways we can improve access to medicines.
learn more

-

Jun 2, 2023

As clinical oncologists gathered in Chicago to meet at the American Society of Clinical Oncology (ASCO)’s Annual Meeting, PhRMA held a media briefing to discuss critical issues facing the future of cancer research and treatment.

Reporters heard from Stephen J. Ubl, President and CEO of PhRMA, alongside industry and patient advocacy leaders on impacts the Inflation Reduction Act (IRA) will have on the research and development (R&D) of cancer treatments. The group also shared the results of a new analysis from the Partnership for Health Analytics and Research (PHAR) on how price setting provisions in the IRA impact R&D for cancer medicines.

learn more

-

Mar 30, 2023

On March 30, PhRMA sponsored The Hill’s event, “Pathways to Patient Affordability,” where PhRMA’s President and Chief Executive Officer, Stephen J. Ubl, joined author and journalist, Kathleen Koch, for a conversation about the barriers to achieving patient affordability. In addition to PhRMA’s sponsored segment, the event included a panel of industry experts, and two conversations with members of Congress. 

learn more

-

Jan 10, 2023

On January 10, as part of PhRMA’s sponsorship of Fierce Pharma’s J.P. Morgan Health Care Conference event, PhRMA’s COO Lori Reilly joined Fierce Pharma’s Rebecca Willumson for a fireside chat on the initial intent of the 340B program, how the program has shifted away from its original purpose and ways to fix the 340B program so that it works for patients.

learn more

-

Jan 9, 2023

On January 9, PhRMA sponsored the “Endpoints at #JPM23” event, where PhRMA’s president and CEO Stephen J. Ubl joined other health care leaders for a panel titled, “What’s really driving the cost of health care in 2023?”

learn more

-

Dec 7, 2022

On December 7, PhRMA sponsored the Axios event, “The Post-Midterm Health Care Agenda,” where PhRMA’s Chief Operating Officer Lori Reilly joined Axios Publisher Nicholas Johnston in a View from the Top segment. Reilly discussed how the results of the 2022 midterm elections will shape the 2023 health care agenda, and laid out industry priorities that will protect and support the interests of patients.

learn more

-

Nov 15, 2022

On November 15, PhRMA’s President and Chief Executive Officer, Stephen J. Ubl, joined Matthew Herper at the STAT Summit to discuss the newly enacted Inflation Reduction Act and how the law harms biopharmaceutical R&D and doesn’t do enough to address patient affordability and access.

learn more

-

Nov 3, 2022
On November 3, PhRMA sponsored The Atlantic’s People v. Cancer event, hosting “PhRMA Presents: The Future of Fighting Cancer.
learn more

-

Oct 4, 2022
On October 4, Dr. Anne Pritchett participated in a conversation with The Economist Impact during The Art of Possible: Reimagining the Biopharmaceutical Supply Chain.
learn more

-

Sep 15, 2022
On September 15, Lisa Joldersma represented PhRMA during The Exchange, Bridging the Gender and Racial Health Gap, hosted by POLITICO Women Rule.
learn more

-

Jul 19, 2022
On July 19, PhRMA’s Jocelyn Ulrich participated at The Hill’s annual Future of Health Care Summit. Jocelyn Ulrich spoke with Bob Cusack, Editor-in-Chief at The Hill, in a fireside chat segment titled Prescriptions for Research and Access.
learn more

-

Jun 28, 2022
On June 28, PhRMA sponsored Foreign Policy’s Global Health Forum, an event that brings together global health experts to discuss imminent public health trends and issues.
learn more

-

Jun 23, 2022
At Aspen Ideas Health 2022, PhRMA sponsored a panel on health equity, Realizing the Promise of Health for All, which was moderated by STAT’s Nicholas St. Fleur.
learn more

-

Jun 22, 2022
At Aspen Ideas Health 2022, Dr. Anne Pritchett participated on the panel After COVID-19: Preventing the Next Pandemic with Dr. Victor Dzau, Dr. Neil Vora, and moderator John Torres of NBC News.
learn more

-

May 15, 2022
On May 11, PhRMA sponsored Live with The 19th: Prioritizing Mental Health, a virtual event hosted by The 19th and State of Mind, a project of Slate magazine and Arizona State University. 
learn more

-

May 9, 2022
On May 9, PhRMA sponsored The Washington Post Live’s virtual event, Coronavirus: Lessons of the Pandemic.
learn more

-

May 4, 2022
On May 4, PhRMA sponsored the Axios virtual event, The Prognosis for Health Care Reform in 2022.
learn more

-

Dec 8, 2021

PhRMA sponsored Axios’ virtual event: Whats Next: Health Care Innovation in 2022. Axios health care reporter Caitlin Owens unpacked pandemic-era innovations and the impact on health care in 2022 and beyond.

learn more

-

Nov 17, 2021

As part of the annual STAT Summit, PhRMA President and CEO Stephen J. Ubl spoke with STAT’s Matthew Herper to discuss the many unintended consequences expected from the latest drug pricing plan on Capitol Hill, as well as the biopharmaceutical industry’s plans to help build a better health care system that improves patient access and protects innovation.

learn more

-

Nov 3, 2021

PhRMA sponsored the Aspen Security Forum and participated in the session Defeating the Virus: The Biden Administration’s Global Vaccination Pledge. This panel discussion was moderated by Kavita Patel, Nonresident Senior Fellow at the Brookings Institution.

learn more

-

Oct 7, 2021

PhRMA sponsored The Washington Post Live event: Health Equity: Affordability. Speakers discussed efforts to make health care more affordable in the United States and deliver innovative, quality care to a wider swath of Americans in the aftermath of the COVID-19 pandemic.

learn more

-

Jul 27, 2021
Efforts to modernize Medicare are once again gathering momentum in the nation’s capital. The current debate centers around cutting costs for patients, while also encouraging drug innovation, research and development. Should the government be able to negotiate drug prices in Medicare? What can Congress do to lower costs for prescription drugs for seniors and people with disabilities? Can Medicare be improved to help patients access care and afford their medications?
learn more

-

Jun 22, 2021

The groundbreaking medical research happening today is laying the foundation for a new golden era of medicine. Clinical trials are a vital step in not just ensuring that new innovations are effective, but that they work for all patients.

learn more

-

May 19, 2021

Axios hosted a virtual event on the COVID-19 vaccine rollout. Axios co-founder Mike Allen and health care reporter Caitlin Owens unpacked the unprecedented COVID-19 vaccine development process as well as the road ahead, featuring NIAID Director Anthony Fauci and Pfizer chairman & CEO Albert Bourla.

learn more

-

Apr 20, 2021
From delaying medical care and putting off doctor visits, to struggling to access adequate services ‒ health care in the traditional sense had largely been put on hold during the COVID-19 pandemic.
But now, as vaccines bring hope that the nation may soon begin to emerge from this crisis, longstanding concerns will have to be addressed. High out-of-pocket costs and surprise medical bills remain a top challenge for patients, as does the ability to access quality health insurance that meets their needs.
learn more

-

Apr 14, 2021

Black and Brown Americans have been disproportionately impacted by the COVID-19 pandemic, experiencing a significant share of the devastating health and economic impact of the virus. While vaccines are critical to saving lives and getting the country back to normal, many individuals have questions about getting vaccinated. Black and Brown Americans in particular have important questions and seek to understand how the vaccines were developed and ensuring their safety and efficacy.

learn more

-

Mar 17, 2021

PhRMA sponsored the Washington Post Live event: The Lessons of a Pandemic. The event was hosted by Paige Winfield Cunningham, and focused on various lessons learned over the course of the COVID-19 pandemic. Those lessons included vaccinating children, vaccine research and hesitancy, new CDC guidance, and the biopharmaceutical industry’s work to combat the pandemic.

learn more

-

Dec 9, 2020
PhRMA recently sponsored The Hill’s From Platform to Policy: 2021 Health Care Agenda event to discuss the future of health care in a new political climate.
learn more

-

Nov 19, 2020
The coronavirus pandemic continues to reshape our country and the world, particularly when it comes to challenging the perception of “what’s possible” in biopharmaceutical innovation. PhRMA recently sponsored STAT News' 2020 health summit convening leading health care CEOs, researchers, thought leaders, policymakers, physicians and health policy experts.
learn more

-

Aug 18, 2020
PhRMA and Bloomberg recently hosted a virtual event to discuss how the ongoing COVID-19 crisis continues to shape the evolution of the clinical and research ecosystem and what we will need to combat future health care challenges.
learn more

-

Jul 9, 2020

On July 9, 2020, The Hill gathered public health officials, policymakers and leaders from across the healthcare ecosystem to dive into the biggest medical and healthcare trends and innovations, considering both longitudinal trends and their interplay with the recent global health pandemic.

learn more

-

Jul 9, 2020
This virtual event launched the AMR Action Fund, a partnership that aims to bring 2-4 new antibiotics to patients by 2030. These treatments are urgently needed to address the rapid rise of antibiotic-resistant infections – also called antimicrobial resistance, or AMR. The fund will invest approximately $1 billion to ensure a robust and diverse pipeline of new medicines to treat drug-resistant infections. 
Learn More

-

Jun 16, 2020
An on-the-record briefing about where the biopharmaceutical industry is in the process of researching and developing potential treatments, vaccines and diagnostics for COVID-19.
learn more

-

May 28, 2020
As part of a livestreamed three-part series, McClatchy is bringing together top-rated medical professionals, industry experts, patient advocates and policymakers to discuss the latest advancements to combat the virus. The first event’s focus will be innovation and treatment; McClatchy will explore from three perspectives how our country can accelerate research and innovation toward treatments for patients suffering from COVID-19. The following installments will focus on the path to a vaccine and the long-term impact of this crisis on health care policy. 
Learn More

-

Apr 14, 2020
For this online event, The Atlantic convened experts fighting COVID-19 on the front lines—doctors, public health officials and pharmaceutical executives. They shared their latest insights, news about potential treatments and what the immediate future holds.
Learn More

-

Apr 8, 2020
The pandemic caused by the novel coronavirus has shut down countries around the world. STAT held a three-part digital event series that brought together experts to discuss one of society’s biggest hopes – that treatments or even vaccines can be developed. The audience was joined by executives from companies leading the way in developing treatments and they discussed current findings, clinical trials and efforts to expedite approvals as we face this global pandemic.
Learn More

-

Jul 25, 2019
PhRMA Innovation Day convened over 175 digital health stakeholders, including member company R&D, regulatory, and digital leadership alongside patient groups, investors, key opinion drivers, and policy makers to chart the potential for the digitalization of the healthcare ecosystem.
learn more

-

May 8, 2019
Baby Boomers face rising medical costs. At the same time, Medicare is growing, and taking up a greater share of the federal budget. While the Trump administration and Congress consider changes to Medicare, how can we keep costs in line, while also giving older Americans the care they need? The Atlantic gathered government officials, healthcare experts, and patient advocates to discuss the path forward for Medicare.
learn More

-

May 1, 2019
From 1990 to 2016, the share of women in the life sciences industry increased from 34 to 47 percent. Women also make up more than half of Ph.Ds. in biological and agricultural sciences. And many researchers are working to address health issues affecting women, ranging from endometriosis to heart conditions. Industry leaders, policymakers and academics have also shown how they’re dedicated to continuing to support innovation — and this includes fostering the next generation of scientists.
learn More

-

Nov 28, 2018
Medicine is improving at a breakneck pace; breakthroughs such as immunotherapy and genetics are changing the way we treat cancer. New drugs are being approved at an unprecedented rate while artificial intelligence and deep learning, until recently just science fiction, are actually starting to make a real difference in public health. The big question now: how can we take this kindling and set it ablaze?
Learn More

-

Nov 14, 2018
Cancer isn’t as lethal as it once was, and yet more than 600,000 Americans are estimated to die from it this year alone, making this complex set of diseases the second leading cause of death in the country. But hope is rising: big data, immuno-oncology and once-in-a-generation medical advances have led to dramatic breakthroughs. New insights into the disease have pushed boundaries, with patients receiving uniquely personalized care.
learn More

-

Oct 3, 2018
How can Washington and the private sector work together to manage the cost of health care and deliver value to consumers? The two-part event will feature health care industry CEOs discussing the evolution of the pharmaceutical business model and a reevaluation of priorities including production of personalized medicines, R&D, and care for chronic diseases.
learn more

-

Sep 17, 2018
An estimated 5.7 million people in this country have Alzheimer’s. And the search for a treatment or a cure has not been promising. In the documentary, Turning Point, filmmaker James Keach, follows a team of scientists on the front lines of Alzheimer’s research and captures the disappointment and renewed hope of those working to disrupt the disease.
learn More

-

Sep 12, 2018
The history of Alzheimer’s research has been filled with setback after setback – in fact nearly every clinical trial has failed – but it is also one marked by perseverance and renewed hope. Advancements in medical imaging have increased our understanding of how the disease strikes, and efforts are underway to develop diagnostics to treat the disease before its onset.
learn More

-

Jul 17, 2018
America is a laboratory for ideas – a testing ground to advance human thought and potential from which entire industries have been born – from media and entertainment, to tech giants capitalizing on the great internet awakening, to scientific discoveries and life-saving cures.
learn more

-

May 23, 2018
The Atlantic gathered key perspectives to continue the conversation on what it costs to stay healthy in America today.
learn More

-

May 3, 2018
PhRMA and POLITICO joined together for a deep-dive conversation on the state of the pharmaceutical supply chain and what can be done to better control costs.
Learn More

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.